Apeloa Pharmaceutical Co.,Ltd financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥830.52M ¥1.04B ¥1.18B ¥1.04B ¥1.25B ¥1.37B ¥1.52B ¥2.81B ¥3.48B ¥3.86B ¥4.23B ¥4.34B ¥4.77B ¥5.55B ¥6.38B ¥7.21B ¥7.88B ¥8.94B ¥10.54B ¥11.47B ¥0.00M
GM % Gross Margin %
19.16% 19.51% 19.34% 18.70% 18.54% 20.90% 20.29% 19.34% 22.59% 22.43% 25.59% 26.66% 27.35% 30.36% 31.50% 31.91% 27.66% 26.43% 23.42% 24.86% 0.00%
OM Operating Margin
8.48% 7.72% 7.83% 5.96% 4.66% 4.96% 3.83% 5.42% 6.78% 5.82% 7.81% 5.65% 5.76% 6.72% 6.60% 8.37% 10.45% 10.73% 8.60% 9.39% 0.00%
EPS Earnings Per Share
¥0.08 ¥0.03 ¥-0.01 ¥0.01 ¥0.14 ¥0.71 ¥0.71 ¥0.88 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.09 ¥0.06 ¥0.07 ¥0.07 ¥0.00 ¥0.00 ¥0.24 ¥0.29 ¥0.30 ¥0.32 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 40.85% 42.25% 36.36% 0
Sha. Shares
568.42m 568.42m 568.42m 667.51m 667.51m 667.51m 667.51m 667.51m 667.51m 1060.09m 1146.87m 1146.87m 1146.87m 1178.52m 1178.52m 1178.52m 1178.52m 1178.52m 1170.96m 0m 1169.32m
OCF Operating Cash Flow
¥47.54M ¥0.00M ¥159.43M ¥174.20M ¥94.57M ¥208.30M ¥121.05M ¥404.62M ¥335.90M ¥190.45M ¥786.64M ¥441.16M ¥180.42M ¥209.80M ¥832.82M ¥1.36B ¥1.06B ¥611.75M ¥1.33B ¥1.03B ¥0.00M
FCF Free Cash Flow
¥-63.53M ¥0.00M ¥105.59M ¥58.50M ¥-254.47M ¥114.64M ¥-18.76M ¥-173.16M ¥-3.69M ¥-314.56M ¥281.31M ¥-10.90M ¥-150.93M ¥46.38M ¥751.20M ¥1.33B ¥742.41M ¥-86.30M ¥821.87M ¥273.00M ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥0.00 ¥0.19 ¥0.09 ¥-0.38 ¥0.17 ¥-0.03 ¥-0.18 ¥-0.00 ¥-0.30 ¥0.23 ¥-0.01 ¥-0.13 ¥0.04 ¥0.64 ¥1.13 ¥0.63 ¥-0.08 ¥0.70 ¥0.34 ¥0.00